Christoph Waer
Senior Investment Manager @ Korys
Leuven, Belgium
Christoph Waer is a Series B investor at Korys in Leuven focused on Medical and Biotechnology. Christoph Waer joined Korys in 2012 as investment analyst to support the three investment lines. Prior to that, he was active as a Junior Analyst in the Paris offices of Fortis Bank (now BNP Paribas) at the Corporate Finance and Capital Markets department. He then joined iPierian, a San Francisco biotech start-up company, as a financial analyst.Christoph earned a MSc in Bioengineering, a MSc in Applied Economics at the KU Leuven (Belgium) and holds a MSc in International Management from the IAE Aix-en-Provence (France). Christoph likes to travel and is an avid soccer player.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Christoph Waer invests in
Stages Christoph Waer invests in
Countries Christoph Waer invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
reMYND
|
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models.They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugscurrently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. | $13.7M / Series B / Dec 18, 2018 |
Co-Investors
About Korys
Korys is the name chosen by the Colruyt family for their investment structure. The name Korys is derived from the Latin word for hazelnut tree – Corylus - which is at the origin of the Colruyt name.Their multi-disciplinary approach enables us to create a well-balanced, diversified portfolio of listed stocks and bonds, private equity funds, anddirect participations in small and medium-sized companies. Through their investments, they aim to make a positive impact on people and the planet, while generating attractive returns. A “three P” approach (People, Planet, Profit) forms the cornerstone of their investment strategy. They invest for the long term, as they realize that it takes time to achieve the sustainable impact they are aiming for. They focus their investments in sectors in which they have built substantial expertise as a team: Cleantech, consumer goods & retail and life sciences.
Korys Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Vincent Vliebergh
Managing Partner
|
|||
|
Christoph Waer
Senior Investment Manager
|
|||
|
Dirk Creado
Founder and Managing Partner
|
|||
Dries Colpaert
Managing Partner
|
|||
Dries Crevits
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Christoph Waer invest in?
Christoph Waer invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christoph Waer?
Public channels for Christoph Waer include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christoph Waer last invest?
The most recent investment recorded for Christoph Waer closed in Dec 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
